97 related articles for article (PubMed ID: 8228273)
1. Accurate and rapid assessment of MHC antigen upregulation following cytokine stimulation.
Gillott DJ; Nouri AM; Compton SJ; Oliver RT
J Immunol Methods; 1993 Oct; 165(2):231-9. PubMed ID: 8228273
[TBL] [Abstract][Full Text] [Related]
2. Comparative assessment of MHC antigen expression in bladder and testis tumour biopsies and established urological tumour cell lines: the relevance of cytokine and gene transfection for correction of defective MHC antigens.
Nouri AM; Symes MO
Oncol Rep; 2000; 7(5):959-64. PubMed ID: 10948322
[TBL] [Abstract][Full Text] [Related]
3. The frequency of major histocompatibility complex antigen abnormalities in urological tumours and their correction by gene transfection or cytokine stimulation.
Nouri AM; Hussain RF; Oliver RT
Cancer Gene Ther; 1994 Jun; 1(2):119-23. PubMed ID: 7621243
[TBL] [Abstract][Full Text] [Related]
4. Defective expression of adhesion molecules on human bladder tumour and human tumour cell lines.
Nouri AM; Hussain RF; Dos Santos AV; Oliver RT
Urol Int; 1996; 56(1):6-12. PubMed ID: 8903546
[TBL] [Abstract][Full Text] [Related]
5. Intensity of class I antigen expression on human tumour cell lines and its relevance to the efficiency of non-MHC-restricted killing.
Nouri AM; Hussain RF; Dos Santos AV; Mansouri M; Oliver RT
Br J Cancer; 1993 Jun; 67(6):1223-8. PubMed ID: 8512807
[TBL] [Abstract][Full Text] [Related]
6. MHC class I and II expression in prostate carcinoma and modulation by interferon-alpha and -gamma.
Bander NH; Yao D; Liu H; Chen YT; Steiner M; Zuccaro W; Moy P
Prostate; 1997 Dec; 33(4):233-9. PubMed ID: 9397194
[TBL] [Abstract][Full Text] [Related]
7. Major histocompatibility complex class I and class II expression in renal cell carcinoma and modulation by interferon gamma.
Gastl G; Ebert T; Finstad CL; Sheinfeld J; Gomahr A; Aulitzky W; Bander NH
J Urol; 1996 Jan; 155(1):361-7. PubMed ID: 7490887
[TBL] [Abstract][Full Text] [Related]
8. Isolation of human leukocyte antigen (HLA)-associated peptide(s) in the absence of HLA-restricted specific cytolytic T lymphocytes.
Torabi-Pour N; Nouri AM; Saffie R; Morrow WJ; Oliver RT
Urol Int; 2002; 69(3):219-26. PubMed ID: 12372891
[TBL] [Abstract][Full Text] [Related]
9. Effect of gamma interferon on HLA class-I and -II transcription and protein expression in human breast adenocarcinoma cell lines.
Jabrane-Ferrat N; Faille A; Loiseau P; Poirier O; Charron D; Calvo F
Int J Cancer; 1990 Jun; 45(6):1169-76. PubMed ID: 2112515
[TBL] [Abstract][Full Text] [Related]
10. Cooperative effect of interferon-gamma and tumor necrosis factor-alpha on the induction of the class II antigen-associated invariant chain expression.
Pessara U; Momburg F; Koch N
Eur J Immunol; 1988 Nov; 18(11):1719-26. PubMed ID: 3144453
[TBL] [Abstract][Full Text] [Related]
11. Schwann cells co-cultured with stimulated T cells and antigen express major histocompatibility complex (MHC) class II determinants without interferon-gamma pretreatment: synergistic effects of interferon-gamma and tumor necrosis factor on MHC class II induction.
Kingston AE; Bergsteinsdottir K; Jessen KR; Van der Meide PH; Colston MJ; Mirsky R
Eur J Immunol; 1989 Jan; 19(1):177-83. PubMed ID: 2493382
[TBL] [Abstract][Full Text] [Related]
12. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
[TBL] [Abstract][Full Text] [Related]
13. MHC antigen induction by interferon gamma on cultured mouse pancreatic beta cells and macrophages. Genetic analysis of strain differences and discovery of an "occult" class I-like antigen in NOD/Lt mice.
Leiter EH; Christianson GJ; Serreze DV; Ting AT; Worthen SM
J Exp Med; 1989 Oct; 170(4):1243-62. PubMed ID: 2507727
[TBL] [Abstract][Full Text] [Related]
14. RB and a novel E2F-1 binding protein in MHC class II deficient B-cell lines and normal IFN-gamma induction of the class IL transactivator CIITA in class II non-inducible RB-defective tumor lines.
Tschickardt ME; Lu Y; Jacim M; Ussery GD; Steimle V; Mach B; Blanck G
Int J Cancer; 1995 Aug; 62(4):461-5. PubMed ID: 7635572
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of DF3, in association with ICAM-1 and MHC class II by IFN-gamma in short-term human mammary carcinoma cell cultures.
Sgagias MK; Nieroda C; Yannelli JR; Cowan KH; Danforth DN
Cancer Biother Radiopharm; 1996 Jun; 11(3):177-85. PubMed ID: 10851535
[TBL] [Abstract][Full Text] [Related]
16. Immunochemical and biochemical characterization of purified canine interferon-gamma. Production of a monoclonal antibody, affinity purification, and its effect on mixed lymphocyte culture and mixed lymphocyte kidney culture reactions.
Fuller L; Fernandez J; Zheng S; Carreno M; Esquenazi V; Yang WC; Miller J
Transplantation; 1992 Jan; 53(1):195-202. PubMed ID: 1531093
[TBL] [Abstract][Full Text] [Related]
17. Induction of HLA class-II antigen expression on human carcinoma cell lines by IFN-Gamma.
Schwartz R; Momburg F; Moldenhauer G; Dörken B; Schirrmacher V
Int J Cancer; 1985 Feb; 35(2):245-50. PubMed ID: 3918946
[TBL] [Abstract][Full Text] [Related]
18. HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta.
Shaw AR; Chan JK; Reid S; Seehafer J
J Natl Cancer Inst; 1985 Jun; 74(6):1261-8. PubMed ID: 3923246
[TBL] [Abstract][Full Text] [Related]
19. Growth and major histocompatibility antigen expression regulation by IL-4, interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) on human renal cell carcinoma.
Hillman GG; Puri RK; Kukuruga MA; Pontes JE; Haas GP
Clin Exp Immunol; 1994 Jun; 96(3):476-83. PubMed ID: 8004818
[TBL] [Abstract][Full Text] [Related]
20. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
